Related Experiment Video
Updated: Jul 26, 2025
Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells
Published on: February 20, 2015
Radiated tumor cell-derived microparticles effectively kill stem-like tumor cells by increasing reactive oxygen
Yan Hu1, Chao Wan1, Xiao Yang1
1Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
Stem-like tumor cells (SLTCs) are thought to be the cellular entity responsible for clinical recurrence and subsequent metastasis. Inhibiting or killing SLTCs can effectively reduce recurrence and metastasis, yet little has been done to clear SLTCs because they are usually resistant to chemotherapy, radiotherapy, and even immunotherapy. In this study, we established SLTCs by low-serum culture and confirmed that the low-serum-cultured tumor cells were in a quiescent state and resistant to chemotherapy, showing features of SLTCs, consistent with the reported data. We demonstrated that SLTCs had high levels of reactive oxygen species (ROS). Based on the finding that radiated tumor cell-derived microparticles (RT-MPs) contained ROS, we used RT-MPs to kill SLTCs. We found that RT-MPs could further increase ROS levels and kill SLTCs in vivo and in vitro partially by ROS carried by the RT-MPs themselves, providing a new method for eliminating SLTCs.
Insights
This study introduces a novel method to eliminate stem-like tumor cells (SLTCs), which drive cancer recurrence. Radiated tumor cell-derived microparticles (RT-MPs) effectively kill these resistant SLTCs by increasing reactive oxygen species (ROS).
Area of Science:
- Oncology
- Cell Biology
- Biotechnology
Background:
- Stem-like tumor cells (SLTCs) are implicated in cancer recurrence and metastasis due to their resistance to conventional therapies.
- Current therapeutic strategies struggle to effectively eliminate SLTCs, highlighting a critical unmet need in cancer treatment.
- SLTCs exhibit a quiescent state and high levels of reactive oxygen species (ROS), presenting unique therapeutic vulnerabilities.
Purpose of the Study:
- To establish and characterize stem-like tumor cells (SLTCs) resistant to conventional therapies.
- To investigate the potential of radiated tumor cell-derived microparticles (RT-MPs) as a novel therapeutic agent against SLTCs.
- To elucidate the mechanism by which RT-MPs eliminate SLTCs, focusing on reactive oxygen species (ROS).
Main Methods:
- Establishment of SLTCs through low-serum culture.
- Characterization of SLTCs for quiescence, chemotherapy resistance, and ROS levels.
- Treatment of SLTCs with radiated tumor cell-derived microparticles (RT-MPs) both in vitro and in vivo.
- Assessment of ROS levels and cell viability following RT-MP treatment.
Main Results:
- Low-serum culture successfully generated SLTCs exhibiting quiescence and chemotherapy resistance.
- SLTCs were found to possess high endogenous levels of reactive oxygen species (ROS).
- RT-MPs significantly increased ROS levels in SLTCs and demonstrated potent killing effects both in vitro and in vivo.
- The anti-SLTC efficacy of RT-MPs was partially attributed to the ROS carried within the microparticles.
Conclusions:
- Radiated tumor cell-derived microparticles (RT-MPs) represent a promising new strategy for eliminating chemotherapy-resistant stem-like tumor cells (SLTCs).
- The mechanism of action involves the elevation of reactive oxygen species (ROS) by RT-MPs, leading to SLTC death.
- This approach offers a potential breakthrough in preventing cancer recurrence and metastasis by targeting the root cause.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:17The Tumor Microenvironment